Niklas Blomberg is the Executive Director of Innovative Health Initiative JU (IHI.europa.eu).
Niklas joined IHI, the European public-private partnership for health research and innovation, in 2024. Prior to IHI he spend 10 years as the founding Director of for the European life science research data infrastructure ELIXIR and 14 years with AstraZeneca, leading teams across Sweden and UK.
Niklas is a Swedish national, with undergraduate studies in biochemistry at University of Gothenburg, and a PhD in structural biology and bioinformatics from the European Molecular Biology Laboratory in Germany.
In the IHI Public-Private partnership Niklas enjoys the unique opportunity to bring together industry, academic and civil society across the healthcare sector – from pharmaceuticals and biotechnology to medical technology and big data – and drive projects that address public health needs, improve patients’ lives, and boost the competitiveness of Europe’s health industries.